Valor Backs Genomics SaaS Platform Allelica

11 Mar, 2021

Valor Backs Genomics SaaS Platform Allelica
Photo by Alex wong on Unsplash

Valor Ventures Fund 2 is pleased to announce its seventh investment, a $1.75m Series Seed financing of Allelica, Inc.
– Valor General Partner Gary Peat joins the Allelica board of directors.
– In addition to lead investor Valor Ventures, participants in the round included AI-focused venture fund Pi Campus and prestigious genetics research institution Medical Genetics Center (MGZ) in Munich as a strategic investor.
– Allelica brings precision medicine into mainstream clinical practice through a Software-as-a-Service platform for the prediction of complex, genetic diseases using proprietary polygenic risk scores.
– With major customers across three continents, Allelica is poised to be the first mass adoption of precision medicine.

Biotechnology Genetics Health Care Life Science Machine Learning Medical North America Predictive Analytics
Crunchbase icon

Content report

The following text will be sent to our editors: